Transanal minimally invasive rectal resection with total mesorectal excision after endoscopic mucosal resection

Česká verzia

Authors: L. Kunovsky ^1,2; Z. Kala ¹; R. Svatoň ¹; M. Dastych ²; R. Kroupa ² ; Jiří Dolina ² ; T. Grolich ¹; V. Čan ¹; V. Procházka ¹
Authors place of work: Chirurgická klinika LF MU a FN Brno ¹; Interní gastroenterologická klinika LF MU a FN Brno ²
Published in the journal: Gastroent Hepatol 2017; 71(3): 208-214
Category: Digestive Endoscopy: Review Article
doi: https://doi.org/10.14735/amgh2017208

Summary

Rectal cancer constitutes a serious oncological problem, and treatment of this disease involves a multidisciplinary team. Nowadays, rectal cancer constitutes more than a quarter of newly diagnosed colorectal cancers in the Czech Republic. Almost 70% of colorectal cancers develop from adenomatous polyps. Benign lesions such as adenoma or hyperplastic polyps can be treated endoscopically. In addition, in non-invasive malignant lesions (which are limited to the mucosa), endoscopic resection is considered curative. If certain criteria are met, endoscopic local excision can be considered a fully curative procedure, even in invasive cancer (cut-off limit: submucosa layer SM2). In patients with an unfavourable tumour grade, with carcinoma invading the submucosal layer (SM3), the cancer cannot be treated endoscopically by endoscopic mucosal resection (EMR) or endoscopic submucosal dissection and surgery is indicated. In some cases, endoscopic treatment can be inadequate and a surgical procedure has to be performed. During 2014–2015, four patients in our department underwent EMR to treat flat mucosal lesions 4–8 cm from the anal verge; however, local excision was not oncologically radical enough, and the patients were indicated for surgical resection. In these patients, a rectal resection with coloanal anastomosis was performed by transanal minimally invasive surgery (TAMIS), a new method that combines mini-invasive surgery with radical surgery resection without a permanent stoma, while meeting oncological radicality criteria. TAMIS can be beneficially used in patients after EMR if histology is promptly evaluated. Total mesorectal excision (TME), i.e., the removal of the fat coating surrounding the rectum along with its lymphatic nodes, has already become a standard surgical treatment for rectal cancer. TAMIS can be used for rectal resection with TME without the need for a stoma, even in low rectal cancer. Adverse histological results after EMR do not necessarily need to lead to an indication for rectal resection with a permanent stoma, but there is a possibility of intersphincteric resection with total lymphadenectomy.

Key words:
rectal cancer – endoscopic mucosal resection – rectal surgery – transanal minimally invasive surgery – total mesorectal excision

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
7. 9. 2016

Accepted:
4. 1. 2017

Zdroje

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (5): E359–E386. doi: 10.1002/ijc.29210.

2. Dušek L, Májek O, Mužík J et al. Objektivní potřeba a stav nádorové prevence v České republice a v Evropě. Klin Onkol 2014; 27 (Suppl 2): 2S7–2S18. doi: 10.14735/amko20142S7.

3. Bláha M, Hoch J, Ferko A et al. Technické zajištění sběru dat pro parametrické sledování totální mezorektální excize (TME) pro karcinom rekta. Rozhl Chir 2016; 95 (7): 272–279.

4. Nussbaum N, Altomare I. The neoadjuvant treatment of rectal cancer: a review. Curr Oncol Rep 2015; 17 (3): 434. doi: 10.1007/s11912-014-0434-9.

5. Valentini V, Aristei C, Glimelius B et al. Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2). Radiother Oncol 2009; 92 (2): 148–163. doi: 10.1016/j.radonc.2009.06.027.

6. Dušek T, Ferko A, Blaha M et al. Současný stav strategie léčby karcinomu rekta v České republice s ohledem na výskyt kompletní patologické odpovědi při neoadjuvantní léčbě – studie PATOD C20 2011–2012. Rozhl Chir 2015; 94 (7): 276–282.

7. van Leersum NJ, Janssen-Heijnen ML, Wouters MW et al. Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995–2010. Int J Cancer 2013; 132 (9): 2157–2163. doi: 10.1002/ijc.27871.

8. Tanaka S, Sano Y. Aim to unify the narrow band imaging (NBI) magnifying classification for colorectal tumors: current status in Japan from a summary of the consensus symposium in the 79th Annual Meeting of the Japan Gastroenterological Endoscopy Society. Dig Endosc 2011; 23 (Suppl 1): 131–139. doi: 10.1111/j.1443-1661.2011.01106.x.

9. Hewett DG, Kaltenbach T, Sano Y et al. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology 2012; 143 (3): 599–607. doi: 10.1053/j.gastro.2012.05.006.

10. Hayashi N, Tanaka S, Hewett DG et al. Endoscopic prediction of deep submucosal invasive carcinoma: validation of the Narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc 2013; 78 (4): 625–632. doi: 10.1016/j.gie.2013.04.185.

11. Uno Y, Munakata A. The non-lifting sign of invasive colon cancer. Gastrointest Endosc 1994; 40 (4): 485–489.

12. Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37 (6): 570–578.

13. Kudo Se, Lambert R, Allen JI et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008; 68 (Suppl 4): S3–S47. doi: 10.1016/j.gie.2008.07.052.

14. Lambert R, Tanaka S. Laterally spreading tumors in the colon and rectum. Eur J Gastroenterol Hepatol 2012; 24 (10): 1123–1134. doi: 10.1097/MEG.0b013e328355e2d9.

15. Morson BC, Bussey HJ, Samoorian S. Policy of local excision for early cancer of the colorectum. Gut 1977; 18 (12): 1045–1050.

16. Morson BC, Whiteway JE, Jones EA et al. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 1984; 25 (5): 437–444.

17. Pizarro-Moreno A, Cordero-Fernández C, Garzón-Benavides M et al. Malignant colonic adenomas. Therapeutic criteria. Long-term results of therapy in a series of 42 patients in our healthcare area. Rev Esp Enferm Dig 2009; 101 (12): 830–836.

18. Haggitt RC, Glotzbach RE, Soffer EE et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89 (2): 328–336.

19. Dastych M, Kroupa R. Možnosti endoskopického řešení polypoidních a nepolypoidních lézí v kolon. Vnitř Lék 2015; 61 (7–8): 698–702.

20. Tanaka S, Oka S, Chayama K. Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J Gastroenterol 2008; 43 (9): 641–651. doi: 10.1007/s00535-008-2223-4.

21. Cao Y, Liao C, Tan A et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009; 41 (9): 751–757. doi: 10.1055/s-0029-1215053.

22. Chao G, Zhang S, Si J. Comparing endoscopic mucosal resection with endoscopic submucosal dissection: the different endoscopic techniques for colorectal tumors. J Surg Res 2016; 202 (1): 204–215. doi: 10.1016/j.jss.2015.12.027.

23. Kala Z, Skrovina M, Procházka V et al. Transanální totální mezorektální excize pro karcinom rekta – jen módní trend? Rozhl Chir 2014; 93 (12): 564–567.

24. Hoch J, Ferko A, Bláha M et al. Parametrické sledování kvality totální mezorektální excize a chirurgické léčby karcinomu rekta – výsledky multicentrické studie. Rozhl Chir 2016; 95 (7): 262–271.

25. Nagtegaal ID, van de Velde CJ, van der Worp E et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20 (7): 1729–1734.

26. Nagtegaal ID, van de Velde CJ, Marijnen CA et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23 (36): 9257–9264.

27. West NP, Finan PJ, Anderin C et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008; 26 (21): 3517–3522. doi: 10.1200/JCO.2007. 14.5961.

28. Rullier E, Denost Q, Vendrely V et al. Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum 2013; 56 (5): 560–567. doi: 10.1097/DCR. 0b013e31827c4a8c.

29. Cranley JP, Petras RE, Carey WD et al. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 1986; 91 (2): 419–427.

30. Nivatvongs S, Rojanasakul A, Reiman HM et al. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum 1991; 34 (4): 323–328.

31. Nascimbeni R, Burgart LJ, Nivatvongs S et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45 (2): 200–206.

32. Noura S, Ohue M, Miyoshi N et al. Transanal minimally invasive surgery (TAMIS) with a GelPOINT® path for lower rectal cancer as an alternative to transanal endoscopic microsurgery (TEM). Mol Clin Oncol 2016; 5 (1): 148–152.

33. Park SU, Min YW, Shin JU et al. Endoscopic submucosal dissection or transanal endoscopic microsurgery for nonpolypoid rectal high grade dysplasia and submucosa-invading rectal cancer. Endoscopy 2012; 44 (11): 1031–1036. doi: 10.1055/s-0032-1310015.

34. Kawaguti FS, Nahas CS, Marques CF et al. Endoscopic submucosal dissection versus transanal endoscopic microsurgery for the treatment of early rectal cancer. Surg Endosc 2014; 28 (4): 1173–1179.

35. Hasegawa S, Takahashi R, Hida K et al. Transanal total mesorectal excision for rectal cancer. Surg Today 2015; 46 (6): 641–653. doi: 10.1007/s00595-015-1195-2.

36. Buchs NC, Nicholson GA, Ris F et al. Transanal total mesorectal excision: a valid option for rectal cancer? World J Gastroenterol 2015; 21 (41): 11700–11708. doi: 10.3748/wjg.v21.i41.11700.

37. Muratore A, Mellano A, Marsanic P et al. Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short-and mid-term results. Eur J Surg Oncol 2015; 41 (4): 478–483. doi: 10.1016/j.ejso.2015.01.009.

38. Lacy AM, Tasende MM, Delgado S et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 2015; 221 (2): 415–423. doi: 10.1016/j.jamcollsurg.2015.03.046